Aim: To assess the prevalence of Coronary Heart Disease (CHD) and Metabolic Syndrome (MS) in patients treated wit
WOS: 000424878600022Introduction: Metabolic syndrome is highly prevalent in patients with schizophre...
Patients affected by psychotic disorders are more likely to develop high rates of co-morbidities, su...
Patients affected by psychotic disorders are more likely to develop high rates of co-morbidities, su...
Cardiometabolic risk assessment in patients with schizophrenia SUMMARY The mortality due to cardiova...
Metabolic syndrome and other cardiovascular risk factors are highly prevalent in people with schizop...
BACKGROUND: Cardiovascular morbidity and mortality are higher in patients with schizophrenia than in...
Cardiovascular morbidity and mortality are important problems among patients with schizophrenia. A w...
People with schizophrenia are at greater risk of obesity, Type 2 diabetes, dyslipidaemia and hyperte...
The presence of the metabolic syndrome is an important risk factor for cardiovascular disease and di...
Individuals with schizophrenia have high levels of medical comorbidity and cardiovascular risk facto...
Background: People with schizophrenia-spectrum disorders (SSD) often have high levels of obesity and...
BACKGROUND: Patients with schizophrenia spectrum disorders (SSD) have worse physical health and redu...
# The Author(s) 2013. This article is published with open access at Springerlink.com Abstract Severe...
Metabolic Syndrome (MetS) is one of the most common factors underlying the high rate of mortality ob...
<p>Many studies have previously shown increased cardiovascular risk factors related to schizophrenia...
WOS: 000424878600022Introduction: Metabolic syndrome is highly prevalent in patients with schizophre...
Patients affected by psychotic disorders are more likely to develop high rates of co-morbidities, su...
Patients affected by psychotic disorders are more likely to develop high rates of co-morbidities, su...
Cardiometabolic risk assessment in patients with schizophrenia SUMMARY The mortality due to cardiova...
Metabolic syndrome and other cardiovascular risk factors are highly prevalent in people with schizop...
BACKGROUND: Cardiovascular morbidity and mortality are higher in patients with schizophrenia than in...
Cardiovascular morbidity and mortality are important problems among patients with schizophrenia. A w...
People with schizophrenia are at greater risk of obesity, Type 2 diabetes, dyslipidaemia and hyperte...
The presence of the metabolic syndrome is an important risk factor for cardiovascular disease and di...
Individuals with schizophrenia have high levels of medical comorbidity and cardiovascular risk facto...
Background: People with schizophrenia-spectrum disorders (SSD) often have high levels of obesity and...
BACKGROUND: Patients with schizophrenia spectrum disorders (SSD) have worse physical health and redu...
# The Author(s) 2013. This article is published with open access at Springerlink.com Abstract Severe...
Metabolic Syndrome (MetS) is one of the most common factors underlying the high rate of mortality ob...
<p>Many studies have previously shown increased cardiovascular risk factors related to schizophrenia...
WOS: 000424878600022Introduction: Metabolic syndrome is highly prevalent in patients with schizophre...
Patients affected by psychotic disorders are more likely to develop high rates of co-morbidities, su...
Patients affected by psychotic disorders are more likely to develop high rates of co-morbidities, su...